{"id":27164,"date":"2017-12-19T12:00:00","date_gmt":"2017-12-19T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/"},"modified":"2017-12-19T12:00:00","modified_gmt":"2017-12-19T12:00:00","slug":"mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/","title":{"rendered":"mySinusitisCoach : l&#8217;autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--2770 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>La technologie de sant\u00e9 mobile \u00e9merge et s\u2019impose comme un outil majeur dans la prise en charge des maladies chroniques. Ces technologies visent \u00e0 renforcer l\u2019autonomisation des patients gr\u00e2ce \u00e0 l\u2019\u00e9ducation et \u00e0 l\u2019autogestion. \u00c0 ce jour, parmi les diff\u00e9rentes applications disponibles pour les patients atteints de pathologies sinusiennes, aucune n\u2019a \u00e9t\u00e9 d\u00e9velopp\u00e9e par des experts m\u00e9dicaux prenant en charge la rhinosinusite chronique (RSC). Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur les allergies et les maladies des voies a\u00e9riennes (EUFOREA) a adopt\u00e9 une approche multipartite pour concevoir, d\u00e9velopper et mettre en \u0153uvre un outil destin\u00e9 \u00e0 aider les patients atteints de RSC \u00e0 surveiller leurs sympt\u00f4mes et \u00e0 leur fournir une plateforme num\u00e9rique de soutien contenant des informations m\u00e9dicales fiables sur leur maladie et les options de traitement. mySinusitisCoach a \u00e9t\u00e9 d\u00e9velopp\u00e9 par des experts m\u00e9dicaux prenant en charge la RSC, en \u00e9troite collaboration avec des patients, des m\u00e9decins de premier recours et des pharmaciens d\u2019officine, afin de r\u00e9pondre aux besoins des patients comme des professionnels de sant\u00e9. Du point de vue de la recherche, la production de donn\u00e9es en vie r\u00e9elle contribuera \u00e0 valider les \u00e9tudes cliniques, la stratification des patients et \u00e0 am\u00e9liorer la compr\u00e9hension de l\u2019impact socio-\u00e9conomique de la RSC, ouvrant ainsi la voie \u00e0 de meilleures strat\u00e9gies th\u00e9rapeutiques.     <\/p>\n<p><strong>Co-auteurs :<\/strong>  S.F. Seys, J. Bousquet, C. Bachert, W.J. Fokkens, I. Agache, M. Bernal- Sprekelsen, I. Callebaut, L.O. Cardel, S. Carrie, P. Castelnuovo, R. Cathcart, J. Constantinidis, L. Cools, M. Cornet, G. Clement, J.C. de Sousa, T. Cox, M. Doulaptsi, P. Gevaert, C. Hopkins, V. Hox, T. Hummel, W. Hosemann, R. Jacobs, M. Jorissen, B.N. Landis, A. Leunig, V.J. Lund, J. Mullol, M. Onerci, S. Palkonen, I. Proano, E. Prokopakis, D. Ryan, H. Riechelmann, J. Saevels, C. Segboer, K. Speleman, E.A. Steinsvik, P. Surda, P.V. Tomazic, O. Vanderveken, L. Van Gerven, T. Van Zele, B. Verhaeghe, K. Vierstraete, S. Vlaminck, J. Wilkinson, S. Williams, B. Pugin, P.W. Hellings<\/p>\n<p><span class=\"button-ckeditor button-ckeditor--blue\"><a href=\"https:\/\/www.rhinologyjournal.com\/Abstract.php?id=1786\" target=\"_blank\" rel=\"noopener\"><strong>Lire l\u2019article ici<\/strong><\/a><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph photo-gallery paragraph-id--2776 paragraph--type--photo-gallery paragraph--view-mode--default clearfix p-photo-gallery--col\">\n<div class=\"photo-gallery__content\">\n<div class=\"paragraph photo paragraph-id--2771 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-1.-Multi-stakeholder-approach-from-design-to-implementation.-1.png?itok=EIgKabmK%20\" data-caption=\"Figure 1. Multi-stakeholder approach from design to implementation.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-1.-Multi-stakeholder-approach-from-design-to-implementation.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2772 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-2.-Key-functionalities-of-mySinusitisCoach.-1.png?itok=d44A7tvh%20\" data-caption=\"Figure 2. Key functionalities of mySinusitisCoach.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-2.-Key-functionalities-of-mySinusitisCoach.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2773 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-3.-Patient-empowerment-through-feedback-to-the-patient-and-the-physician.-1.png?itok=TSgvd5lv%20\" data-caption=\"Figure 3. Patient empowerment through feedback to the patient and the physician.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-3.-Patient-empowerment-through-feedback-to-the-patient-and-the-physician.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2774 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-4.-Patient-empowerment-via-patient-education.-1.png?itok=iSBFZgJ1%20\" data-caption=\"Figure 4. Patient empowerment via patient education.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-4.-Patient-empowerment-via-patient-education.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<div class=\"paragraph photo paragraph-id--2775 paragraph--type--photo paragraph--view-mode--default clearfix\">\n<p><a href=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-5.-Expected-benefits-of-mySinusitiscoach-for-the-different-stake-holders.-1.png?itok=Sn18qbKb%20\" data-caption=\"Figure 5. Expected benefits of mySinusitiscoach for the different stake- holders.\" data-fancybox=\"images\"><br \/>\n<img decoding=\"async\" src=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-5.-Expected-benefits-of-mySinusitiscoach-for-the-different-stake-holders.png\"><br \/>\n<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La technologie de sant\u00e9 mobile \u00e9merge et s\u2019impose comme un outil majeur dans la prise en charge des maladies chroniques. Ces technologies visent \u00e0 renforcer l\u2019autonomisation des patients gr\u00e2ce \u00e0 l\u2019\u00e9ducation et \u00e0 l\u2019autogestion. \u00c0 ce jour, parmi les diff\u00e9rentes applications disponibles pour les patients atteints de pathologies sinusiennes, aucune n\u2019a \u00e9t\u00e9 d\u00e9velopp\u00e9e par des experts m\u00e9dicaux prenant en charge la rhinosinusite chronique (RSC). Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur les allergies et les maladies des voies a\u00e9riennes (EUFOREA) a adopt\u00e9 une approche multipartite pour concevoir, d\u00e9velopper et mettre en \u0153uvre un outil destin\u00e9 \u00e0 aider les patients atteints de RSC \u00e0 surveiller leurs sympt\u00f4mes et \u00e0 leur fournir une plateforme num\u00e9rique de soutien contenant des informations m\u00e9dicales fiables sur leur maladie et les options de traitement. mySinusitisCoach a \u00e9t\u00e9 d\u00e9velopp\u00e9 par des experts m\u00e9dicaux prenant en charge la RSC, en \u00e9troite collaboration avec des patients, des m\u00e9decins de premier recours et des pharmaciens d\u2019officine, afin de r\u00e9pondre aux besoins des patients comme des professionnels de sant\u00e9. Du point de vue de la recherche, la production de donn\u00e9es en vie r\u00e9elle contribuera \u00e0 valider les \u00e9tudes cliniques, la stratification des patients et \u00e0 am\u00e9liorer la compr\u00e9hension de l\u2019impact socio-\u00e9conomique de la RSC, ouvrant ainsi la voie \u00e0 de meilleures strat\u00e9gies th\u00e9rapeutiques. Co-auteurs : S.F. Seys, J. Bousquet, C. Bachert, W.J. Fokkens, I. Agache, M. Bernal- Sprekelsen, I. Callebaut, L.O. Cardel, S. Carrie, P. Castelnuovo, R. Cathcart, J. Constantinidis, L. Cools, M. Cornet, G. Clement, J.C. de Sousa, T. Cox, M. Doulaptsi, P. Gevaert, C. Hopkins, V. Hox, T. Hummel, W. Hosemann, R. Jacobs, M. Jorissen, B.N. Landis, A. Leunig, V.J. Lund, J. Mullol, M. Onerci, S. Palkonen, I. Proano, E. Prokopakis, D. Ryan, H. Riechelmann, J. Saevels, C. Segboer, K. Speleman, E.A. Steinsvik, P. Surda, P.V. Tomazic, O. Vanderveken, L. Van Gerven, T. Van Zele, B. Verhaeghe, K. Vierstraete, S. Vlaminck, J. Wilkinson, S. Williams, B. Pugin, P.W. Hellings Lire l\u2019article ici<\/p>\n","protected":false},"author":1,"featured_media":27176,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[266],"tags":[195,284,194],"class_list":["post-27164","news","type-news","status-publish","has-post-thumbnail","hentry","category-publications","tag-maladies-respiratoires-chroniques-mrc","tag-publications","tag-rhinosinusite-chronique-rsc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>mySinusitisCoach : l&#039;autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"mySinusitisCoach : l&#039;autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile\" \/>\n<meta property=\"og:description\" content=\"La technologie de sant\u00e9 mobile \u00e9merge et s\u2019impose comme un outil majeur dans la prise en charge des maladies chroniques. Ces technologies visent \u00e0 renforcer l\u2019autonomisation des patients gr\u00e2ce \u00e0 l\u2019\u00e9ducation et \u00e0 l\u2019autogestion. \u00c0 ce jour, parmi les diff\u00e9rentes applications disponibles pour les patients atteints de pathologies sinusiennes, aucune n\u2019a \u00e9t\u00e9 d\u00e9velopp\u00e9e par des experts m\u00e9dicaux prenant en charge la rhinosinusite chronique (RSC). Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur les allergies et les maladies des voies a\u00e9riennes (EUFOREA) a adopt\u00e9 une approche multipartite pour concevoir, d\u00e9velopper et mettre en \u0153uvre un outil destin\u00e9 \u00e0 aider les patients atteints de RSC \u00e0 surveiller leurs sympt\u00f4mes et \u00e0 leur fournir une plateforme num\u00e9rique de soutien contenant des informations m\u00e9dicales fiables sur leur maladie et les options de traitement. mySinusitisCoach a \u00e9t\u00e9 d\u00e9velopp\u00e9 par des experts m\u00e9dicaux prenant en charge la RSC, en \u00e9troite collaboration avec des patients, des m\u00e9decins de premier recours et des pharmaciens d\u2019officine, afin de r\u00e9pondre aux besoins des patients comme des professionnels de sant\u00e9. Du point de vue de la recherche, la production de donn\u00e9es en vie r\u00e9elle contribuera \u00e0 valider les \u00e9tudes cliniques, la stratification des patients et \u00e0 am\u00e9liorer la compr\u00e9hension de l\u2019impact socio-\u00e9conomique de la RSC, ouvrant ainsi la voie \u00e0 de meilleures strat\u00e9gies th\u00e9rapeutiques. Co-auteurs : S.F. Seys, J. Bousquet, C. Bachert, W.J. Fokkens, I. Agache, M. Bernal- Sprekelsen, I. Callebaut, L.O. Cardel, S. Carrie, P. Castelnuovo, R. Cathcart, J. Constantinidis, L. Cools, M. Cornet, G. Clement, J.C. de Sousa, T. Cox, M. Doulaptsi, P. Gevaert, C. Hopkins, V. Hox, T. Hummel, W. Hosemann, R. Jacobs, M. Jorissen, B.N. Landis, A. Leunig, V.J. Lund, J. Mullol, M. Onerci, S. Palkonen, I. Proano, E. Prokopakis, D. Ryan, H. Riechelmann, J. Saevels, C. Segboer, K. Speleman, E.A. Steinsvik, P. Surda, P.V. Tomazic, O. Vanderveken, L. Van Gerven, T. Van Zele, B. Verhaeghe, K. Vierstraete, S. Vlaminck, J. Wilkinson, S. Williams, B. Pugin, P.W. Hellings Lire l\u2019article ici\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-1.-Multi-stakeholder-approach-from-design-to-implementation.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/\",\"name\":\"mySinusitisCoach : l'autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png\",\"datePublished\":\"2017-12-19T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"mySinusitisCoach : l&#8217;autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"mySinusitisCoach : l'autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/","og_locale":"fr_FR","og_type":"article","og_title":"mySinusitisCoach : l'autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile","og_description":"La technologie de sant\u00e9 mobile \u00e9merge et s\u2019impose comme un outil majeur dans la prise en charge des maladies chroniques. Ces technologies visent \u00e0 renforcer l\u2019autonomisation des patients gr\u00e2ce \u00e0 l\u2019\u00e9ducation et \u00e0 l\u2019autogestion. \u00c0 ce jour, parmi les diff\u00e9rentes applications disponibles pour les patients atteints de pathologies sinusiennes, aucune n\u2019a \u00e9t\u00e9 d\u00e9velopp\u00e9e par des experts m\u00e9dicaux prenant en charge la rhinosinusite chronique (RSC). Le Forum europ\u00e9en pour la recherche et l\u2019\u00e9ducation sur les allergies et les maladies des voies a\u00e9riennes (EUFOREA) a adopt\u00e9 une approche multipartite pour concevoir, d\u00e9velopper et mettre en \u0153uvre un outil destin\u00e9 \u00e0 aider les patients atteints de RSC \u00e0 surveiller leurs sympt\u00f4mes et \u00e0 leur fournir une plateforme num\u00e9rique de soutien contenant des informations m\u00e9dicales fiables sur leur maladie et les options de traitement. mySinusitisCoach a \u00e9t\u00e9 d\u00e9velopp\u00e9 par des experts m\u00e9dicaux prenant en charge la RSC, en \u00e9troite collaboration avec des patients, des m\u00e9decins de premier recours et des pharmaciens d\u2019officine, afin de r\u00e9pondre aux besoins des patients comme des professionnels de sant\u00e9. Du point de vue de la recherche, la production de donn\u00e9es en vie r\u00e9elle contribuera \u00e0 valider les \u00e9tudes cliniques, la stratification des patients et \u00e0 am\u00e9liorer la compr\u00e9hension de l\u2019impact socio-\u00e9conomique de la RSC, ouvrant ainsi la voie \u00e0 de meilleures strat\u00e9gies th\u00e9rapeutiques. Co-auteurs : S.F. Seys, J. Bousquet, C. Bachert, W.J. Fokkens, I. Agache, M. Bernal- Sprekelsen, I. Callebaut, L.O. Cardel, S. Carrie, P. Castelnuovo, R. Cathcart, J. Constantinidis, L. Cools, M. Cornet, G. Clement, J.C. de Sousa, T. Cox, M. Doulaptsi, P. Gevaert, C. Hopkins, V. Hox, T. Hummel, W. Hosemann, R. Jacobs, M. Jorissen, B.N. Landis, A. Leunig, V.J. Lund, J. Mullol, M. Onerci, S. Palkonen, I. Proano, E. Prokopakis, D. Ryan, H. Riechelmann, J. Saevels, C. Segboer, K. Speleman, E.A. Steinsvik, P. Surda, P.V. Tomazic, O. Vanderveken, L. Van Gerven, T. Van Zele, B. Verhaeghe, K. Vierstraete, S. Vlaminck, J. Wilkinson, S. Williams, B. Pugin, P.W. Hellings Lire l\u2019article ici","og_url":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","og_image":[{"url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Figure-1.-Multi-stakeholder-approach-from-design-to-implementation.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/","url":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/","name":"mySinusitisCoach : l'autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png","datePublished":"2017-12-19T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/mySinusitisCoach20Patient20empowerment20in20chronic20rhinosinusitis20using20mobile20technology20Teaser20.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/mysinusitiscoach-lautonomisation-des-patients-atteints-de-rhinosinusite-chronique-grace-a-la-technologie-mobile\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"mySinusitisCoach : l&#8217;autonomisation des patients atteints de rhinosinusite chronique gr\u00e2ce \u00e0 la technologie mobile"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/27164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=27164"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/27164\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/27176"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=27164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=27164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=27164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}